Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 281

MSU starts student-run VC fund

MSU’s Student Venture Capital Fund will invest up to $50,000 in university-linked businesses with the administrative aid of MSU students taking the entrepreneurial finance course.

Apr 23, 2019

Deciphex decodes $2.6m

Based at DCU Invent, Deciphex has gained investors including Inova and GI Partners as it looks to refine its offering for the toxicologic and gastrointestinal segments of pathology.

Apr 23, 2019

Michigan marks Applied Morphomics

Applied Morphomics has formally spun out of University of Michigan to deliver a medical analytics service powered by morphological scans of patients.

Apr 23, 2019

IIT-D prepares deep tech strategy

Indian Institute of Technology-Delhi will launch a deep tech incubator and innovation strategy on the back of its recent success in becoming an Indian government-sponsored institute of eminence.

Apr 23, 2019

Mind Foundry discerns Parkwalk funding

The follow-on investment complements $1.7m raised by Oxford data analytics spinout Mind Foundry in 2016 from investors including Oxford Sciences Innovation.

Apr 23, 2019

Think-Lands needles $3m

Building on Chiba and Hokkaido university research, Think-Lands is aiming to commercialise microneedles manufactured with its optical vortex production system.

Apr 23, 2019

Oxford spinouts score $61m in first quarter

The total raised by Oxford’s spinouts was down from $229m year-on-year, though university tech transfer office OUI also marked its largest ever single exit during the period.

Apr 23, 2019

Cytura sits atop of seed round

Building on KU Leuven and Amsterdam UMC research, Cytura hopes to find small molecule candidates that combat the issue of genomic variability in cancer.

Apr 23, 2019

Talaris takes home $100m series A

Talaris, previously known as Regenerex and based on research at University of Louisville, will use the funding to advance its cell therapy into later-stage clinical development.

Apr 23, 2019

Arrakis arranges $75m series B

Osage University has returned for a $75m series B round raised by Arrakis Therapeutics, which has licensed technology from University of Pennsylvania.

Apr 23, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here